← back to search

Yukinori Koyama

University of California San Diego · JP
Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Disease Diagnosis and Treatment, Liver physiology and pathology, Hepatocellular Carcinoma Treatment and Prognosis, and Organ Transplantation Techniques and Outcomes.
h-index
24
citations
3,670
works
89
NIH funding
primary concept
Medicine
email

Recent publications

Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution
Gastroenterology 2020cited by 193position: middledoi
Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice
JCI Insight 2020cited by 61position: middledoi
IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease
Journal of Hepatology 2019cited by 206position: middledoi
Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice
Journal of Hepatology 2019cited by 129position: middledoi
NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice
Gastroenterology 2018cited by 87position: middledoi
Liver inflammation and fibrosis
Journal of Clinical Investigation 2017cited by 1,257position: firstdoi
Intestinal fungi contribute to development of alcoholic liver disease
Journal of Clinical Investigation 2017cited by 461position: middledoi
Mesothelin/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis
Journal of Clinical Investigation 2017cited by 107position: firstdoi
The role of human cytochrome P450 2E1 in liver inflammation and fibrosis
Hepatology Communications 2017cited by 73position: middledoi
New Developments on the Treatment of Liver Fibrosis
Digestive Diseases 2016cited by 116position: firstdoi
Promising Therapy Candidates for Liver Fibrosis
Frontiers in Physiology 2016cited by 82position: middledoi
Aging increases the susceptibility of hepatic inflammation, liver fibrosis and aging in response to high-fat diet in mice
AGE 2016cited by 81position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David A. Brenner · Institute of Medical Microbiology and Hygiene9 papers (2016–2020)Jun Xu · University of Science and Technology of China8 papers (2016–2020)Tatiana Kisseleva · University of California San Diego Medical Center7 papers (2016–2020)Hsiao‐Yen Ma · Gene Therapy Laboratory6 papers (2016–2020)Xiao Liu · Nanchang University5 papers (2016–2018)Shuang Liang · Peking University5 papers (2016–2019)Daniel Karin · APLA Health3 papers (2017–2019)Ronglin Hu · University of California San Diego3 papers (2017–2019)In Hee Kim · Chungbuk National University2 papers (2016–2016)Takahiro Nishio · Kyoto University2 papers (2018–2019)Gabriel Karin · University of California, Los Angeles2 papers (2017–2018)Mengxi Sun · Huazhong Agricultural University2 papers (2017–2017)Xiao Liu · Pennsylvania State University2 papers (2019–2020)Keiko Iwaisako · Doshisha University2 papers (2017–2019)Kojiro Taura · Kitano Hospital2 papers (2017–2019)Christopher Benner · UC San Diego Health System2 papers (2017–2020)Debanjan Dhar · Sanford Burnham Prebys Medical Discovery Institute2 papers (2018–2019)Ryan McCubbin · University of California San Diego2 papers (2018–2020)Sven Heinz · UC San Diego Health System2 papers (2017–2020)Ping Wang · Heilongjiang University of Chinese Medicine2 papers (2016–2017)